Overview

Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
A large dose of PPI is effective in preventing peptic ulcer rebleeding. The investigators hypothesize that 40 mg/q6h pantoloc is equivalent to 8mg/h pantoloc in preventing rebleeding.
Phase:
Phase 4
Details
Lead Sponsor:
Lotung Poh-Ai Hospital
Treatments:
Pantoprazole
Proton Pump Inhibitors